Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |